Evidence relates to a population clinically diagnosed with any or a mixture of the following conditions: cerebral infarction, non-traumatic intracerebral haemorrhage.
|
Evidence relates to a study population solely focused on any of the following conditions: transient ischaemic attack (TIA), traumatic brain injury, hypoxic brain injury, subarachnoid haemorrhage.
|
Evidence relates to an adult stroke population at any period post-clinical diagnosis.
|
Evidence relates to a paediatric stroke population.
|
Evidence relates to studies focused on the use of patient-reported outcome measures within routine clinical practice or care at the micro- and/or meso-levels. (incl. pragmatic studies)
|
Evidence relates to studies concentrating on the development of a PROM.
|
Evidence relates to PROMs use at the level of the individual.
|
Evidence relates to studies concentrating on other patient-reported tools such as patient-reported experience measures (PREMs), non-standardised patient-reported outcomes or tools with only a partial patient-reported element.
|
Evidence must relate to studies where PROM score interpretation and/or feedback is necessary.
|
Evidence relates to studies concentrating on secondary testing or comparative testing of PROMs.
|
English language or high-quality translation available.
|
Evidence relates to studies concentrating on the psychometric properties of a PROM or PROMs (e.g. validity and reliability).
|
Any secondary literature, e.g. literature reviews, comments, editorials.
|
Evidence relates to studies involving the aggregation of individual PROM scores.
|
|
Evidence relates to studies in which PROMs are an outcome of a research study, including the evaluation of an intervention or observational research exploring trends in quality of life.
|
|
Any primary research studies understood as involving primary data capture to answer a novel hypothesis either via experimental or observational design (this type of study design is reserved for phase 2: theory testing)
|
|
Date of publication pre 01/01/00 due to the significant changes to stroke care and services.
|